Telisotuzumab (ABT-700) is a human recombinant bivalent antibody designed to target the hepatocyte growth factor receptor (MET). It binds to c-Met with high affinity, effectively inhibiting c-Met signaling. This antibody demonstrates significant antitumor activity, making it a valuable tool for research in cancer therapy, particularly in studies focusing on the role of c-Met in tumor growth and metastasis.
Telisotuzumab (ABT-700) is a human recombinant bivalent antibody designed to target the hepatocyte growth factor receptor (MET). It binds to c-Met with high affinity, effectively inhibiting c-Met signaling. This antibody demonstrates significant antitumor activity, making it a valuable tool for research in cancer therapy, particularly in studies focusing on the role of c-Met in tumor growth and metastasis.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
